Atara Biotherapeutics
ATRA
ATRA
75 hedge funds and large institutions have $477M invested in Atara Biotherapeutics in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% less capital invested
Capital invested by funds: $493M → $477M (-$15.4M)
Holders
75
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.88M | |
| 2 | +$8.8M | |
| 3 | +$4.89M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.85M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.46M |
Top Sellers
| 1 | -$8.41M | |
| 2 | -$6.51M | |
| 3 | -$2.68M | |
| 4 |
JP Morgan Chase
New York
|
-$2.03M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$602K |